ACT May Be Useful In Point-Of-Care Monitoring Of Enoxaprin Anticoagulation Effect In Patients Undergoing PTCA
Intravenous enoxaparin has been found to increase activated clotting time (ACT) at 5 minutes in patients undergoing percutaneous coronary intervention (PCI), indicating […]
1 min read